Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care

Lara M Stepleman, Marie Christine Rutter, Judith Hibbard, Lisa Johns, Dustin Eric Wright, Mary Hughes

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Purpose.Patient engagement in multiple sclerosis (MS) care can be challenging at times given the unpredictable disease course, wide range of symptoms, variable therapeutic response to treatment and high rates of patient depression. Patient activation, a model for conceptualising patients' involvement in their health care, has been found useful for discerning patient differences in chronic illness management. The purpose of this study was to validate the patient activation measure (PAM-13) in an MS clinic sample. Methods.This was a survey study of 199 MS clinic patients. Participants completed the PAM-13 along with measures of MS medication adherence, self-efficacy, depression and quality of life. Results.Results from Rasch and correlation analyses indicate that the PAM-13 is reliable and valid for the MS population. Activation was associated with MS self-efficacy, depression and quality of life but not with self-reported medication adherence. Also, participants with relapse-remitting MS, current employment, or high levels of education were more activated than other subgroups. Conclusions.The PAM-13 is a useful tool for understanding health behaviours in MS. The findings of this study support further clinical consideration and investigation into developing interventions to increase patient activation and improve health outcomes in MS.

Original languageEnglish (US)
Pages (from-to)1558-1567
Number of pages10
JournalDisability and Rehabilitation
Volume32
Issue number19
DOIs
StatePublished - Aug 4 2010

Fingerprint

Patient Participation
Multiple Sclerosis
Medication Adherence
Self Efficacy
Depression
Quality of Life
Health Behavior
Chronic Disease
Delivery of Health Care
Education
Recurrence

Keywords

  • Multiple sclerosis
  • illness behaviour
  • patient activation
  • patient compliance
  • self-efficacy

ASJC Scopus subject areas

  • Rehabilitation

Cite this

Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care. / Stepleman, Lara M; Rutter, Marie Christine; Hibbard, Judith; Johns, Lisa; Wright, Dustin Eric; Hughes, Mary.

In: Disability and Rehabilitation, Vol. 32, No. 19, 04.08.2010, p. 1558-1567.

Research output: Contribution to journalArticle

Stepleman, Lara M ; Rutter, Marie Christine ; Hibbard, Judith ; Johns, Lisa ; Wright, Dustin Eric ; Hughes, Mary. / Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care. In: Disability and Rehabilitation. 2010 ; Vol. 32, No. 19. pp. 1558-1567.
@article{02b3b004ae614c819b5e1bd6e0c9d90d,
title = "Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care",
abstract = "Purpose.Patient engagement in multiple sclerosis (MS) care can be challenging at times given the unpredictable disease course, wide range of symptoms, variable therapeutic response to treatment and high rates of patient depression. Patient activation, a model for conceptualising patients' involvement in their health care, has been found useful for discerning patient differences in chronic illness management. The purpose of this study was to validate the patient activation measure (PAM-13) in an MS clinic sample. Methods.This was a survey study of 199 MS clinic patients. Participants completed the PAM-13 along with measures of MS medication adherence, self-efficacy, depression and quality of life. Results.Results from Rasch and correlation analyses indicate that the PAM-13 is reliable and valid for the MS population. Activation was associated with MS self-efficacy, depression and quality of life but not with self-reported medication adherence. Also, participants with relapse-remitting MS, current employment, or high levels of education were more activated than other subgroups. Conclusions.The PAM-13 is a useful tool for understanding health behaviours in MS. The findings of this study support further clinical consideration and investigation into developing interventions to increase patient activation and improve health outcomes in MS.",
keywords = "Multiple sclerosis, illness behaviour, patient activation, patient compliance, self-efficacy",
author = "Stepleman, {Lara M} and Rutter, {Marie Christine} and Judith Hibbard and Lisa Johns and Wright, {Dustin Eric} and Mary Hughes",
year = "2010",
month = "8",
day = "4",
doi = "10.3109/09638280903567885",
language = "English (US)",
volume = "32",
pages = "1558--1567",
journal = "Disability and Rehabilitation",
issn = "0963-8288",
publisher = "Informa Healthcare",
number = "19",

}

TY - JOUR

T1 - Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care

AU - Stepleman, Lara M

AU - Rutter, Marie Christine

AU - Hibbard, Judith

AU - Johns, Lisa

AU - Wright, Dustin Eric

AU - Hughes, Mary

PY - 2010/8/4

Y1 - 2010/8/4

N2 - Purpose.Patient engagement in multiple sclerosis (MS) care can be challenging at times given the unpredictable disease course, wide range of symptoms, variable therapeutic response to treatment and high rates of patient depression. Patient activation, a model for conceptualising patients' involvement in their health care, has been found useful for discerning patient differences in chronic illness management. The purpose of this study was to validate the patient activation measure (PAM-13) in an MS clinic sample. Methods.This was a survey study of 199 MS clinic patients. Participants completed the PAM-13 along with measures of MS medication adherence, self-efficacy, depression and quality of life. Results.Results from Rasch and correlation analyses indicate that the PAM-13 is reliable and valid for the MS population. Activation was associated with MS self-efficacy, depression and quality of life but not with self-reported medication adherence. Also, participants with relapse-remitting MS, current employment, or high levels of education were more activated than other subgroups. Conclusions.The PAM-13 is a useful tool for understanding health behaviours in MS. The findings of this study support further clinical consideration and investigation into developing interventions to increase patient activation and improve health outcomes in MS.

AB - Purpose.Patient engagement in multiple sclerosis (MS) care can be challenging at times given the unpredictable disease course, wide range of symptoms, variable therapeutic response to treatment and high rates of patient depression. Patient activation, a model for conceptualising patients' involvement in their health care, has been found useful for discerning patient differences in chronic illness management. The purpose of this study was to validate the patient activation measure (PAM-13) in an MS clinic sample. Methods.This was a survey study of 199 MS clinic patients. Participants completed the PAM-13 along with measures of MS medication adherence, self-efficacy, depression and quality of life. Results.Results from Rasch and correlation analyses indicate that the PAM-13 is reliable and valid for the MS population. Activation was associated with MS self-efficacy, depression and quality of life but not with self-reported medication adherence. Also, participants with relapse-remitting MS, current employment, or high levels of education were more activated than other subgroups. Conclusions.The PAM-13 is a useful tool for understanding health behaviours in MS. The findings of this study support further clinical consideration and investigation into developing interventions to increase patient activation and improve health outcomes in MS.

KW - Multiple sclerosis

KW - illness behaviour

KW - patient activation

KW - patient compliance

KW - self-efficacy

UR - http://www.scopus.com/inward/record.url?scp=77955066029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955066029&partnerID=8YFLogxK

U2 - 10.3109/09638280903567885

DO - 10.3109/09638280903567885

M3 - Article

VL - 32

SP - 1558

EP - 1567

JO - Disability and Rehabilitation

JF - Disability and Rehabilitation

SN - 0963-8288

IS - 19

ER -